MENU
CRBU
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Caribou Biosciences (CRBU) Earnings Date & Reports

Caribou Biosciences Inc is a clinical-stage Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) biopharmaceutical company dedicated to transforming the lives of patients with devastating diseases by applying its novel CRISPR platform, CRISPR hybrid RNA-DNA (chRDNA), toward the development of next-generation, genome-edited cell therapies... Show more

A.I. Advisor
published Earnings

CRBU is expected to report earnings to rise 16.23% to -45 cents per share on May 13

Caribou Biosciences CRBU Stock Earnings Reports
Q1'25
Est.
$-0.45
Q4'24
Beat
by $0.03
Q3'24
Beat
by $0.07
Q2'24
Beat
by $0.04
Q1'24
Missed
by $0.06
The last earnings report on March 10 showed earnings per share of -38 cents, beating the estimate of -41 cents. With 800.37K shares outstanding, the current market capitalization sits at 78.23M.
View a ticker or compare two or three
CRBU
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
2929 7th Street
Phone
+1 510 982-6030
Employees
158
Web
https://www.cariboubio.com